{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T13:17:40Z","timestamp":1785417460031,"version":"3.56.0"},"reference-count":57,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,10,28]],"date-time":"2024-10-28T00:00:00Z","timestamp":1730073600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004731","name":"Zhejiang Province Natural Science Foundation","doi-asserted-by":"publisher","award":["LZ21H280001"],"award-info":[{"award-number":["LZ21H280001"]}],"id":[{"id":"10.13039\/501100004731","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82174096"],"award-info":[{"award-number":["82174096"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82374048"],"award-info":[{"award-number":["82374048"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Asian Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1016\/j.ajps.2024.100990","type":"journal-article","created":{"date-parts":[[2024,11,2]],"date-time":"2024-11-02T17:32:50Z","timestamp":1730568770000},"page":"100990","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Biomimetic nanoparticles co-deliver hirudin and lumbrukinase to ameliorate thrombus and inflammation for atherosclerosis therapy"],"prefix":"10.1016","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0009-0000-1182-8880","authenticated-orcid":false,"given":"Mengying","family":"Cheng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianxiang","family":"Yue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lai","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiaoling","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2222-0242","authenticated-orcid":false,"given":"Fanzhu","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10","key":"10.1016\/j.ajps.2024.100990_bib0001","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1016\/j.cell.2022.04.004","article-title":"Atherosclerosis: recent developments","volume":"185","author":"Bjoerkegren","year":"2022","journal-title":"Cell"},{"issue":"7855","key":"10.1016\/j.ajps.2024.100990_bib0002","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1038\/s41586-021-03392-8","article-title":"The changing landscape of atherosclerosis","volume":"592","author":"Libby","year":"2021","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.ajps.2024.100990_bib0003","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1124\/pharmrev.120.000096","article-title":"Endothelial dysfunction in atherosclerotic cardiovascular diseases and beyond: from mechanism to pharmacotherapies","volume":"73","author":"Xu","year":"2021","journal-title":"Pharmacol Rev"},{"issue":"11","key":"10.1016\/j.ajps.2024.100990_bib0004","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1038\/s41569-023-00883-1","article-title":"Flow-induced reprogramming of endothelial cells in atherosclerosis","volume":"20","author":"Tamargo","year":"2023","journal-title":"Nat Rev Cardiol"},{"issue":"1","key":"10.1016\/j.ajps.2024.100990_bib0005","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1038\/s41572-019-0106-z","article-title":"Atherosclerosis","volume":"5","author":"Libby","year":"2019","journal-title":"Nat Rev Dis Prim"},{"issue":"9","key":"10.1016\/j.ajps.2024.100990_bib0006","doi-asserted-by":"crossref","first-page":"2370","DOI":"10.1161\/ATVBAHA.120.315754","article-title":"Thrombus structural composition in cardiovascular disease","volume":"41","author":"Alkarithi","year":"2021","journal-title":"Arterioscler Thrombos Vasc Biol"},{"issue":"10","key":"10.1016\/j.ajps.2024.100990_bib0007","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1038\/nrcardio.2016.111","article-title":"Antithrombotic therapy for secondary prevention of atherothrombotic events in cerebrovascular disease","volume":"13","author":"Capodanno","year":"2016","journal-title":"Nat Rev Cardiol"},{"issue":"9","key":"10.1016\/j.ajps.2024.100990_bib0008","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1038\/s41569-021-00552-1","article-title":"Interplay between inflammation and thrombosis in cardiovascular pathology","volume":"18","author":"Stark","year":"2021","journal-title":"Nat Rev Cardiol"},{"issue":"6","key":"10.1016\/j.ajps.2024.100990_bib0009","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1016\/0092-8674(91)90261-V","article-title":"Molecular cloning of a functional thrombin receptor reveals a novel proteolytic mechanism of receptor activation","volume":"64","author":"Vu","year":"1991","journal-title":"Cell"},{"issue":"2","key":"10.1016\/j.ajps.2024.100990_bib0010","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/j.atherosclerosis.2015.03.023","article-title":"Rivaroxaban, a novel oral anticoagulant, attenuates atherosclerotic plaque progression and destabilization in ApoE-deficient mice","volume":"242","author":"Hara","year":"2015","journal-title":"Atherosclerosis"},{"issue":"4","key":"10.1016\/j.ajps.2024.100990_bib0011","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1161\/CIRCRESAHA.120.317219","article-title":"Different DOACs control inflammation in cardiac ischemia-reperfusion differently","volume":"128","author":"Gadi","year":"2021","journal-title":"Circ Res"},{"issue":"26","key":"10.1016\/j.ajps.2024.100990_bib0012","doi-asserted-by":"crossref","first-page":"2497","DOI":"10.1056\/NEJMoa1912388","article-title":"Efficacy and safety of low-dose colchicine after myocardial infarction","volume":"381","author":"Tardif","year":"2019","journal-title":"New Eng J Med"},{"issue":"12","key":"10.1016\/j.ajps.2024.100990_bib0013","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1056\/NEJMoa1707914","article-title":"Antiinflammatory therapy with canakinumab for atherosclerotic disease","volume":"377","author":"Ridker","year":"2017","journal-title":"New Eng J Med"},{"issue":"8","key":"10.1016\/j.ajps.2024.100990_bib0014","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1056\/NEJMc2034992","article-title":"Colchicine in patients with chronic coronary disease","volume":"384","author":"Gebhard","year":"2021","journal-title":"New Eng J Med"},{"key":"10.1016\/j.ajps.2024.100990_bib0015","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1016\/j.jconrel.2021.08.058","article-title":"Engineering a ``three-in-one'' hirudin prodrug to reduce bleeding risk: a proof-of-concept study","volume":"338","author":"Zhu","year":"2021","journal-title":"J Control Releas"},{"issue":"11","key":"10.1016\/j.ajps.2024.100990_bib0016","doi-asserted-by":"crossref","first-page":"18483","DOI":"10.1021\/acsnano.2c06666","article-title":"Platelet-covered nanocarriers for targeted delivery of hirudin to eliminate thrombotic complication in tumor therapy","volume":"16","author":"Zhang","year":"2022","journal-title":"Acs Nano"},{"key":"10.1016\/j.ajps.2024.100990_bib0017","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2021.121332","article-title":"Microneedle patch-assisted transdermal administration of recombinant hirudin for the treatment of thrombotic diseases","volume":"612","author":"Men","year":"2022","journal-title":"Int J Pharm"},{"issue":"51","key":"10.1016\/j.ajps.2024.100990_bib0018","doi-asserted-by":"crossref","DOI":"10.1002\/smll.202203184","article-title":"Biomimetic nanoplatelets to target delivery hirudin for site-specific photothermal\/photodynamic thrombolysis and preventing venous thrombus formation","volume":"18","author":"Li","year":"2022","journal-title":"Small"},{"issue":"2","key":"10.1016\/j.ajps.2024.100990_bib0019","first-page":"144","article-title":"Synthesis and evaluation of cationic polymeric micelles as carriers of lumbrokinase for targeted thrombolysis","volume":"14","author":"Pan","year":"2019","journal-title":"Asian J Pharmaceut Sci"},{"issue":"1","key":"10.1016\/j.ajps.2024.100990_bib0020","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1080\/03639045.2018.1522324","article-title":"Targeted thrombolysis by using c-RGD-modified N,N,N-trimethyl chitosan nanoparticles loaded with lumbrokinase","volume":"45","author":"Liao","year":"2019","journal-title":"Drug Dev Ind Pharm"},{"key":"10.1016\/j.ajps.2024.100990_bib0021","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.jep.2016.05.028","article-title":"Pheretima aspergillum decoction suppresses inflammation and relieves asthma in a mouse model of bronchial asthma by NF-\u03baB inhibition","volume":"189","author":"Huang","year":"2016","journal-title":"J Ethnopharmacol"},{"issue":"1","key":"10.1016\/j.ajps.2024.100990_bib0022","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.jconrel.2008.03.018","article-title":"Characterization of water-in-oil microemulsion for oral delivery of earthworm fibrinolytic enzyme","volume":"129","author":"Cheng","year":"2008","journal-title":"J Control Releas"},{"key":"10.1016\/j.ajps.2024.100990_bib0023","article-title":"A zombie macrophage-based \"trojan horse\" enhances the effect of efferocytosis through immune regulation for atherosclerosis treatment","author":"Yao","year":"2024","journal-title":"Adv Funct Mater"},{"issue":"1","key":"10.1016\/j.ajps.2024.100990_bib0024","doi-asserted-by":"crossref","first-page":"2622","DOI":"10.1038\/s41467-020-16439-7","article-title":"Treatment of atherosclerosis by macrophage-biomimetic nanoparticles via targeted pharmacotherapy and sequestration of proinflammatory cytokines","volume":"11","author":"Gao","year":"2020","journal-title":"Nat Commun"},{"issue":"2","key":"10.1016\/j.ajps.2024.100990_bib0025","article-title":"A red blood cell-derived bionic microrobot capable of hierarchically adapting to five critical stages in systemic drug delivery","volume":"4","author":"Zhu","year":"2023","journal-title":"Exploration (Beijing)"},{"issue":"11","key":"10.1016\/j.ajps.2024.100990_bib0026","doi-asserted-by":"crossref","first-page":"4442","DOI":"10.1016\/j.apsb.2022.11.014","article-title":"Biomimetic nanomedicines for precise atherosclerosis theranostics","volume":"13","author":"Tao","year":"2023","journal-title":"Acta Pharmaceutica Sinica B"},{"key":"10.1016\/j.ajps.2024.100990_bib0027","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2024.122478","article-title":"Platelet-derived drug delivery systems: pioneering treatment for cancer, cardiovascular diseases, infectious diseases, and beyond","volume":"306","author":"Zhu","year":"2024","journal-title":"Biomaterials"},{"issue":"52","key":"10.1016\/j.ajps.2024.100990_bib0028","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202105348","article-title":"Ischemic microenvironment-responsive therapeutics for cardiovascular diseases","volume":"33","author":"Li","year":"2021","journal-title":"Adv Mat"},{"issue":"0","key":"10.1016\/j.ajps.2024.100990_bib0029","article-title":"Targeted delivery of platelet membrane modified extracellular vesicles into atherosclerotic plaque to regress atherosclerosis","volume":"452","author":"Li","year":"2023","journal-title":"Chem Engineer J"},{"issue":"5","key":"10.1016\/j.ajps.2024.100990_bib0030","doi-asserted-by":"crossref","first-page":"e27166","DOI":"10.1016\/j.heliyon.2024.e27166","article-title":"Platelet-inspired targeting delivery for coronary heart disease","volume":"10","author":"Jiang","year":"2024","journal-title":"Heliyon"},{"issue":"2","key":"10.1016\/j.ajps.2024.100990_bib0031","article-title":"Platelet-derived microparticles and their cargos: the past, present and future","volume":"19","author":"Guo","year":"2024","journal-title":"Asian J Pharmaceut Sci"},{"issue":"24","key":"10.1016\/j.ajps.2024.100990_bib0032","doi-asserted-by":"crossref","first-page":"2482","DOI":"10.1056\/NEJMra071014","article-title":"Platelet activation and atherothrombosis","volume":"357","author":"Davi","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ajps.2024.100990_bib0033","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1182\/blood-2019-121082","article-title":"Nanoparticles mimicking platelets and platelet cloaking","volume":"134","author":"Zhang","year":"2019","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.ajps.2024.100990_bib0034","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1021\/acsnano.7b07720","article-title":"Nanoparticle functionalization with platelet membrane enables multifactored biological targeting and detection of atherosclerosis","volume":"12","author":"Wei","year":"2018","journal-title":"ACS Nano"},{"issue":"15","key":"10.1016\/j.ajps.2024.100990_bib0035","doi-asserted-by":"crossref","DOI":"10.1002\/adhm.202302074","article-title":"Biomimetic platelet-cloaked nanoparticles for the delivery of anti-inflammatory curcumin in the treatment of atherosclerosis","volume":"13","author":"Fontana","year":"2024","journal-title":"Adv Healthc Mater"},{"issue":"3","key":"10.1016\/j.ajps.2024.100990_bib0036","doi-asserted-by":"crossref","first-page":"3740","DOI":"10.1021\/acsami.1c19820","article-title":"Bioresponsive polyphenol-based nanoparticles as thrombolytic drug carriers","volume":"14","author":"Yu","year":"2022","journal-title":"ACS Appl Mater Interface"},{"issue":"36","key":"10.1016\/j.ajps.2024.100990_bib0037","doi-asserted-by":"crossref","first-page":"15618","DOI":"10.1002\/anie.202002089","article-title":"Polyphenol-mediated assembly of proteins for engineering functional materials","volume":"59","author":"Han","year":"2020","journal-title":"Angew Chem Int Ed Engl"},{"issue":"45","key":"10.1016\/j.ajps.2024.100990_bib0038","doi-asserted-by":"crossref","DOI":"10.1002\/anie.202312925","article-title":"Direct assembly of metal-phenolic network nanoparticles for biomedical applications","volume":"62","author":"Xu","year":"2023","journal-title":"Angew Chem Int Ed Engl"},{"issue":"7571","key":"10.1016\/j.ajps.2024.100990_bib0039","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1038\/nature15373","article-title":"Nanoparticle biointerfacing by platelet membrane cloaking","volume":"526","author":"Hu","year":"2015","journal-title":"Nature"},{"issue":"4","key":"10.1016\/j.ajps.2024.100990_bib0040","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.thromres.2004.06.046","article-title":"Platelet glycoprotein VI: its structure and function","volume":"114","author":"Moroi","year":"2004","journal-title":"Thromb Res"},{"issue":"9","key":"10.1016\/j.ajps.2024.100990_bib0041","doi-asserted-by":"crossref","first-page":"3577","DOI":"10.1182\/blood-2004-08-2980","article-title":"Platelet homeostasis is regulated by platelet expression of CD47 under normal conditions and in passive immune thrombocytopenia","volume":"105","author":"Olsson","year":"2005","journal-title":"Blood"},{"issue":"13","key":"10.1016\/j.ajps.2024.100990_bib0042","doi-asserted-by":"crossref","first-page":"11432","DOI":"10.1021\/acs.chemrev.1c01042","article-title":"Metal ion-directed functional metal-phenolic materials","volume":"122","author":"Geng","year":"2022","journal-title":"Chem Rev"},{"issue":"22","key":"10.1016\/j.ajps.2024.100990_bib0043","doi-asserted-by":"crossref","first-page":"5546","DOI":"10.1002\/anie.201311136","article-title":"Engineering multifunctional capsules through the assembly of metal-phenolic networks","volume":"53","author":"Guo","year":"2014","journal-title":"Angew Chem Int Ed Engl"},{"issue":"45","key":"10.1016\/j.ajps.2024.100990_bib0044","doi-asserted-by":"crossref","first-page":"50583","DOI":"10.1021\/acsami.2c15205","article-title":"Tannic acid-assisted biomineralization strategy for encapsulation and intracellular delivery of protein drugs","volume":"14","author":"Yin","year":"2022","journal-title":"ACS Appl Mater Interfaces"},{"issue":"15","key":"10.1016\/j.ajps.2024.100990_bib0045","doi-asserted-by":"crossref","first-page":"14555","DOI":"10.1021\/acsnano.3c01420","article-title":"Design of a multifunctional nanozyme for resolving the proinflammatory plaque microenvironment and attenuating atherosclerosis","volume":"17","author":"He","year":"2023","journal-title":"ACS Nano"},{"issue":"12","key":"10.1016\/j.ajps.2024.100990_bib0046","doi-asserted-by":"crossref","first-page":"3211","DOI":"10.1172\/JCI29499","article-title":"Complete reversal of acid-induced acute lung injury by blocking of platelet-neutrophil aggregation","volume":"116","author":"Zarbock","year":"2006","journal-title":"J Clin Invest"},{"issue":"7","key":"10.1016\/j.ajps.2024.100990_bib0047","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1080\/09537100020019157","article-title":"Structural determinants within platelet glycoprotein Ibalpha involved in its binding to von Willebrand factor","volume":"11","author":"Cauwenberghs","year":"2000","journal-title":"Platelets"},{"key":"10.1016\/j.ajps.2024.100990_bib0048","doi-asserted-by":"crossref","first-page":"15559","DOI":"10.1038\/ncomms15559","article-title":"Leukocyte integrin Mac-1 regulates thrombosis via interaction with platelet GPIb\u03b1","volume":"8","author":"Wang","year":"2017","journal-title":"Nat Commun"},{"issue":"9","key":"10.1016\/j.ajps.2024.100990_bib0049","doi-asserted-by":"crossref","first-page":"8943","DOI":"10.1021\/acsnano.8b02037","article-title":"Targeted therapy of atherosclerosis by a broad-spectrum reactive oxygen species scavenging nanoparticle with intrinsic anti-inflammatory activity","volume":"12","author":"Wang","year":"2018","journal-title":"ACS Nano"},{"issue":"1","key":"10.1016\/j.ajps.2024.100990_bib0050","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1038\/s41392-022-00955-7","article-title":"Inflammation and atherosclerosis: signaling pathways and therapeutic intervention","volume":"7","author":"Kong","year":"2022","journal-title":"Signal Transduct Target Ther"},{"issue":"7","key":"10.1016\/j.ajps.2024.100990_bib0051","first-page":"389","article-title":"Inflammation and its resolution in atherosclerosis: mediators and therapeutic opportunities","volume":"16","author":"Back","year":"2019","journal-title":"Nat Rev Cardiol"},{"issue":"29","key":"10.1016\/j.ajps.2024.100990_bib0052","article-title":"Recent Advances in anti-atherosclerosis and potential therapeutic targets for nanomaterial-derived drug formulations","volume":"10","author":"Xiao","year":"2023","journal-title":"Adv Sci (Weinh)"},{"issue":"4","key":"10.1016\/j.ajps.2024.100990_bib0053","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1124\/pr.118.017178","article-title":"Targeting foam cell formation in atherosclerosis: therapeutic potential of natural products","volume":"71","author":"Wang","year":"2019","journal-title":"Pharmacol Rev"},{"issue":"5","key":"10.1016\/j.ajps.2024.100990_bib0054","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1161\/CIRCRESAHA.116.305811","article-title":"Macrophage sortilin promotes LDL uptake, foam cell formation, and atherosclerosis","volume":"116","author":"Patel","year":"2015","journal-title":"Circ. Res."},{"issue":"3","key":"10.1016\/j.ajps.2024.100990_bib0055","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.cell.2011.04.005","article-title":"Macrophages in the pathogenesis of atherosclerosis","volume":"145","author":"Moore","year":"2011","journal-title":"Cell"},{"issue":"12","key":"10.1016\/j.ajps.2024.100990_bib0056","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1038\/s41569-022-00798-3","article-title":"Macropinocytosis promotes foam cell formation and atherosclerosis","volume":"19","author":"Irene","year":"2022","journal-title":"Nat Rev Cardiol"},{"issue":"663","key":"10.1016\/j.ajps.2024.100990_bib0057","doi-asserted-by":"crossref","first-page":"eadd2376","DOI":"10.1126\/scitranslmed.add2376","article-title":"Receptor-independent fluid-phase macropinocytosis promotes arterial foam cell formation and atherosclerosis","volume":"14","author":"Lin","year":"2022","journal-title":"Sci Transl Med"}],"container-title":["Asian Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1818087624001077?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1818087624001077?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,9]],"date-time":"2025-03-09T05:37:17Z","timestamp":1741498637000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1818087624001077"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2]]},"references-count":57,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,2]]}},"alternative-id":["S1818087624001077"],"URL":"https:\/\/doi.org\/10.1016\/j.ajps.2024.100990","relation":{},"ISSN":["1818-0876"],"issn-type":[{"value":"1818-0876","type":"print"}],"subject":[],"published":{"date-parts":[[2025,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Biomimetic nanoparticles co-deliver hirudin and lumbrukinase to ameliorate thrombus and inflammation for atherosclerosis therapy","name":"articletitle","label":"Article Title"},{"value":"Asian Journal of Pharmaceutical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajps.2024.100990","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Published by Elsevier B.V. on behalf of Shenyang Pharmaceutical University.","name":"copyright","label":"Copyright"}],"article-number":"100990"}}